You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API atovaquone and proguanil hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing atovaquone and proguanil hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
GlaxoSmithKline LLC MALARONE atovaquone and proguanil hydrochloride 0173-0675 CELLULOSE, MICROCRYSTALLINE
GlaxoSmithKline LLC MALARONE atovaquone and proguanil hydrochloride 0173-0675 FERRIC OXIDE RED
GlaxoSmithKline LLC MALARONE atovaquone and proguanil hydrochloride 0173-0675 HYPROMELLOSE
GlaxoSmithKline LLC MALARONE atovaquone and proguanil hydrochloride 0173-0675 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing atovaquone and proguanil hydrochloride

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc atovaquone and proguanil hydrochloride 0378-4160 CELLULOSE, MICROCRYSTALLINE
Mylan Pharmaceuticals Inc atovaquone and proguanil hydrochloride 0378-4160 CROSPOVIDONE
Mylan Pharmaceuticals Inc atovaquone and proguanil hydrochloride 0378-4160 FERRIC OXIDE RED
Mylan Pharmaceuticals Inc atovaquone and proguanil hydrochloride 0378-4160 FERRIC OXIDE YELLOW
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for atovaquone and proguanil hydrochloride

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSPOVIDONE

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

atovaquone and proguanil hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Company Ingredient NDC
Blenheim Pharmacal Inc atovaquone and proguanil hydrochloride 10544-909
Aidarex Pharmaceuticals LLC atovaquone and proguanil hydrochloride 33261-900
Rebel Distributors Corp atovaquone and proguanil hydrochloride 42254-150
Physicians Total Care Inc atovaquone and proguanil hydrochloride 54868-6393
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

atovaquone and proguanil hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Company Ingredient NDC
GlaxoSmithKline LLC atovaquone and proguanil hydrochloride 0173-0675
Mylan Pharmaceuticals Inc atovaquone and proguanil hydrochloride 0378-4160
PD-Rx Pharmaceuticals Inc atovaquone and proguanil hydrochloride 43063-393
PD-Rx Pharmaceuticals Inc atovaquone and proguanil hydrochloride 43063-522
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

atovaquone and proguanil hydrochloride drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Company Ingredient NDC
Mylan Pharmaceuticals Inc atovaquone and proguanil hydrochloride 0378-4160
Blenheim Pharmacal Inc atovaquone and proguanil hydrochloride 10544-909
Aidarex Pharmaceuticals LLC atovaquone and proguanil hydrochloride 33261-900
Rebel Distributors Corp atovaquone and proguanil hydrochloride 42254-150
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POLOXAMER 188

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

atovaquone and proguanil hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Mylan Pharmaceuticals Inc atovaquone and proguanil hydrochloride 0378-4160
Blenheim Pharmacal Inc atovaquone and proguanil hydrochloride 10544-909
Aidarex Pharmaceuticals LLC atovaquone and proguanil hydrochloride 33261-900
Rebel Distributors Corp atovaquone and proguanil hydrochloride 42254-150
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: TITANIUM DIOXIDE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group